You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Fluocinolone acetonide (0.19 mg) intravitreal implant reduces treatment burden and improves practice resource utilisation for patients with diabetic macular oedema

Article metrics

Article menu

Download PDFPDF

XML
Original research
Fluocinolone acetonide (0.19 mg) intravitreal implant reduces treatment burden and improves practice resource utilisation for patients with diabetic macular oedema

 

Online download statistics by month:

Online download statistics by month: April 2020 to March 2024

AbstractFullPdf
Apr 202014013640
May 202024124124
Jun 202013513276
Jul 202090899
Aug 202024226
Sep 2020292810
Oct 202037349
Nov 202018174
Dec 202021218
Jan 2021585414
Feb 2021252410
Mar 202142427
Apr 202125236
May 202121208
Jun 202144439
Jul 202128298
Aug 202123238
Sep 202136389
Oct 2021171717
Nov 2021252512
Dec 202115151
Jan 202225247
Feb 202214142
Mar 2022373615
Apr 202217169
May 2022333211
Jun 202228285
Jul 202225246
Aug 202228297
Sep 2022323410
Oct 2022292911
Nov 2022161625
Dec 202217164
Jan 202318174
Feb 2023505210
Mar 202324245
Apr 202315171
May 202313123
Jun 202321226
Jul 202315154
Aug 202319173
Sep 202311110
Oct 202313121
Nov 202323214
Dec 202311120
Jan 202412122
Feb 202411114
Mar 2024161630
Total16671642484